瑞普生物：关于转让控股子公司股权暨募投项目转让的进展公告

Core Viewpoint - The company, Reap Bio, has announced the transfer of a 48.4213% stake in its subsidiary, Hunan Zhong'an Biological Pharmaceutical Co., Ltd., to Jiangxi Twin Biological Technology Co., Ltd. for a transaction price of 114.758426 million yuan, establishing a strategic partnership [2]. Group 1 - The board and supervisory committee of the company approved the proposal for the stake transfer during their meetings held on June 13, 2025 [2]. - Following the transaction, the company will retain a 20% stake in Zhong'an Bio, which will no longer be included in the company's consolidated financial statements [2]. - The stake transfer is related to the fundraising project "Zhong'an Bio Expansion Project," which was part of the company's specific stock issuance in 2021 [2]. Group 2 - The proposal was subsequently approved by the company's third extraordinary general meeting of shareholders held on June 30, 2025 [2]. - The transfer has been completed with the registration of industrial and commercial changes [2].